PARSIPPANY, N.J., May 09, 2022 (GLOBE NEWSWIRE) — Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:
The 2022 RBC Capital Markets Global Healthcare Conference at the Intercontinental NY Barclay Hotel in New York, NY.
- Management will participate in a fireside chat on Wednesday, May 18 at 9:30 a.m. Eastern Time.
The Piper Sandler Ophthalmology and Diabetes Symposium.
- Management will participate in a virtual fireside chat on Wednesday, May 25 at 12:00 p.m. Eastern Time.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company’s investor relations website at https://investors.embecta.com/. The webcasts will be available for replay following the conference.
About embecta
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.
CONTACTS
Investors:
Contact IR
Media:
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
[email protected]
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
